Founders Financial Alliance’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$744K Buy
19,329
+2,047
+12% +$84.4K 0.13% 155
2025
Q4
$711K Sell
17,282
-1,981
-10% -$78.2K 0.13% 151
2025
Q3
$717K Buy
19,263
+2,212
+13% +$80.4K 0.14% 152
2025
Q2
$622K Buy
+17,051
New +$618K 0.14% 146
2024
Q4
Sell
-8,135
Closed -$341K 579
2024
Q3
$341K Buy
8,135
+7
+0.1% +$291 0.1% 205
2024
Q2
$332K Sell
8,128
-2,053
-20% -$81.7K 0.1% 199
2024
Q1
$422K Buy
10,181
+7
+0.1% +$293 0.13% 166
2023
Q4
$412K Sell
10,174
-449
-4% -$17.1K 0.16% 136
2023
Q3
$416K Buy
10,623
+6
+0.1% +$239 0.18% 115
2023
Q2
$431K Buy
10,617
+5
+0% +$206 0.17% 127
2023
Q1
$444K Buy
10,612
+783
+8% +$32.9K 0.22% 108
2022
Q4
$428K Sell
9,829
-320
-3% -$13.6K 0.2% 119
2022
Q3
$394K Buy
+10,149
New +$432K 0.2% 115

Other funds holding BME

Founders Financial Alliance's BME Position: Q1 2026 in Review

Founders Financial Alliance increased its BlackRock Health Sciences Trust (BME) stake by 12% in Q1 2026, buying an estimated $84.4K and bringing the position to 19,329 shares worth $744K. The position accounts for 0.13% of the portfolio, ranked #155.

Founders Financial Alliance first reported a position in BME in Q3 2022 and has held it in 13 quarters since. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Founders Financial Alliance held 19,329 shares of BlackRock Health Sciences Trust worth $744K as of Q1 2026.
  • Founders Financial Alliance bought 2,047 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $84.4K.
  • BlackRock Health Sciences Trust made up 0.13% of Founders Financial Alliance's portfolio in Q1 2026, its #155 holding.
  • Founders Financial Alliance first reported a position in BlackRock Health Sciences Trust in Q3 2022 and has held it in 13 quarters since.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Founders Financial Alliance's 13F filing for Q1 2026, filed 11 May 2026.